ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

Submit article

582-effectiveness-and-safety-of-monoclonal-antibodies-for-metastatic-colorectal-cancer-treatment-systematic-review-and-meta-analysis

Review: Effectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysis

Bruno Rosa, José Paulo de Jesus, Eduardo L de Mello, Daniel Cesar, Mauro M Correia

15 Oct 2015

https://doi.org/10.3332/ecancer.2015.582

Abstract | Full Article | PDF | Portuguese

581-aspirin-in-the-21st-century-common-mechanisms-of-disease-and-their-modulation-by-aspirin-a-report-from-the-2015-scientific-conference-of-the-international-aspirin-foundation-28-august-london-uk

Conference Report: Aspirin in the 21st century—common mechanisms of disease and their modulation by aspirin: a report from the 2015 scientific conference of the international aspirin foundation, 28 August, London, UK

Tom Smith, Pippa Hutchison, Karsten Schrör, Joan Clària, Angel Lanas, Paola Patrignani, Andrew T Chan, Farhat Din, Ruth Langley, Peter Elwood, Andrew Freedman, Ron Eccles

13 Oct 2015

https://doi.org/10.3332/ecancer.2015.581

Abstract | Full Article | PDF

580-training-in-the-prevention-of-cervical-cancer-advantages-of-e-learning

Special Issue: Training in the prevention of cervical cancer: advantages of e-learning

Assumpta Company, Mireia Montserrat, Francesc X Bosch, Silvia de Sanjosé

8 Oct 2015

https://doi.org/10.3332/ecancer.2015.580